Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

June 01, 2001; Volume 59,Issue 6

Perspective

  • You have access
    Prostaglandin EP1 Receptor Subtype Selectivity Takes Shape
    Richard M. Breyer
    Molecular Pharmacology June 2001, 59 (6) 1357-1359; DOI: https://doi.org/10.1124/mol.59.6.1357

Accelerated Communications

  • You have access
    Tyrosine Phosphorylation of the μ-Opioid Receptor Regulates Agonist Intrinsic Efficacy
    Jay P. McLaughlin and Charles Chavkin
    Molecular Pharmacology June 2001, 59 (6) 1360-1368; DOI: https://doi.org/10.1124/mol.59.6.1360
  • You have access
    Role of Fatty Acid Amide Hydrolase in the Transport of the Endogenous Cannabinoid Anandamide
    Theresa A. Day, Fariborz Rakhshan, Dale G. Deutsch and Eric L. Barker
    Molecular Pharmacology June 2001, 59 (6) 1369-1375; DOI: https://doi.org/10.1124/mol.59.6.1369

Articles

  • You have access
    Verapamil Inhibits Proliferation of LNCaP Human Prostate Cancer Cells Influencing K+ Channel Gating
    Volodymr Rybalchenko, Natalia Prevarskaya, Fabien Van Coppenolle, Guillaume Legrand, Loic Lemonnier, Xuefen Le Bourhis and Roman Skryma
    Molecular Pharmacology June 2001, 59 (6) 1376-1387; DOI: https://doi.org/10.1124/mol.59.6.1376
  • You have access
    Pharmacological Separation of the Expression of Tissue Transglutaminase and Apoptosis after Chemotherapeutic Treatment of HepG2 Cells
    Iván P. Uray, Peter J. A. Davies and László Fésüs
    Molecular Pharmacology June 2001, 59 (6) 1388-1394; DOI: https://doi.org/10.1124/mol.59.6.1388
  • You have access
    Arrestin Effects on Internalization of Vasopressin Receptors
    Donna Bowen-Pidgeon, Giulio Innamorati, Hamid M. Sadeghi and Mariel Birnbaumer
    Molecular Pharmacology June 2001, 59 (6) 1395-1401; DOI: https://doi.org/10.1124/mol.59.6.1395
  • You have access
    Repression of Phenobarbital-Dependent CYP2B1 mRNA Induction by Reactive Oxygen Species in Primary Rat Hepatocyte Cultures
    K. I. Hirsch-Ernst, K. Schlaefer, D. Bauer, A. F. Heder and G. F. Kahl
    Molecular Pharmacology June 2001, 59 (6) 1402-1409; DOI: https://doi.org/10.1124/mol.59.6.1402
  • You have access
    An α4β4 Nicotinic Receptor Subtype Is Present in Chick Retina: Identification, Characterization and Pharmacological Comparison with the Transfected α4β4 and α6β4 Subtypes
    Benedetta Barabino, Silvia Vailati, Milena Moretti, J. Michael McIntosh, Renato Longhi, Francesco Clementi and Cecilia Gotti
    Molecular Pharmacology June 2001, 59 (6) 1410-1417; DOI: https://doi.org/10.1124/mol.59.6.1410
  • You have access
    Pharmacological Properties of Peptides Derived from Stromal Cell-Derived Factor 1: Study on Human Polymorphonuclear Cells
    Nikolaus Heveker, Michèle Tissot, Alain Thuret, Jens Schneider-Mergener, Marc Alizon, Monique Roch and Stefano Marullo
    Molecular Pharmacology June 2001, 59 (6) 1418-1425; DOI: https://doi.org/10.1124/mol.59.6.1418
  • You have access
    Chronic Treatment of C6 Glioma Cells with Antidepressant Drugs Results in a Redistribution of Gsα
    Robert J. Donati, Chandrashekhar Thukral and Mark M. Rasenick
    Molecular Pharmacology June 2001, 59 (6) 1426-1432; DOI: https://doi.org/10.1124/mol.59.6.1426
  • You have access
    Nephrotoxicants Induce Endothelin Release and Signaling in Renal Proximal Tubules: Effect on Drug Efflux
    Sylvie A. Terlouw, Rosalinde Masereeuw, Frans G. M. Russel and David S. Miller
    Molecular Pharmacology June 2001, 59 (6) 1433-1440; DOI: https://doi.org/10.1124/mol.59.6.1433
  • You have access
    Insights into the Mechanism of Azithromycin Interaction with anEscherichia coli Functional Ribosomal Complex
    George P. Dinos, Maria Michelinaki and Dimitrios L. Kalpaxis
    Molecular Pharmacology June 2001, 59 (6) 1441-1445; DOI: https://doi.org/10.1124/mol.59.6.1441
  • You have access
    Key Structural Features of Prostaglandin E2 and Prostanoid Analogs Involved in Binding and Activation of the Human EP1 Prostanoid Receptor
    Mark D. Ungrin, Marie-Claude Carrière, Danielle Denis, Sonia Lamontagne, Nicole Sawyer, Rino Stocco, Nathalie Tremblay, Kathleen M. Metters and Mark Abramovitz
    Molecular Pharmacology June 2001, 59 (6) 1446-1456; DOI: https://doi.org/10.1124/mol.59.6.1446
  • You have access
    Novel Wasp Toxin Discriminates between Neuronal and Cardiac Sodium Channels
    Eiji Kinoshita, Hiroshi Maejima, Kaoru Yamaoka, Katsuhiro Konno, Nobufumi Kawai, Eisuke Shimizu, Sawana Yokote, Hitoshi Nakayama and Issei Seyama
    Molecular Pharmacology June 2001, 59 (6) 1457-1463; DOI: https://doi.org/10.1124/mol.59.6.1457
  • You have access
    Analysis of Opioid Binding to UDP-Glucuronosyltransferase 2B7 Fusion Proteins Using Nuclear Magnetic Resonance Spectroscopy
    Birgit L. Coffman, William R. Kearney, Mitchell D. Green, Robert G. Lowery and Thomas R. Tephly
    Molecular Pharmacology June 2001, 59 (6) 1464-1469; DOI: https://doi.org/10.1124/mol.59.6.1464
  • You have access
    Differential Cross Talk of ROD Compounds with the Benzodiazepine Binding Site
    Erwin Sigel, Roland Baur, Roman Furtmueller, Rodolphe Razet, Robert H. Dodd and Werner Sieghart
    Molecular Pharmacology June 2001, 59 (6) 1470-1477; DOI: https://doi.org/10.1124/mol.59.6.1470
  • You have access
    Different Molecular Mechanisms of Vitamin D3 Receptor Antagonists
    Andrea Toell, Manuel Macias Gonzalez, Dagmar Ruf, Andreas Steinmeyer, Seiichi Ishizuka and Carsten Carlberg
    Molecular Pharmacology June 2001, 59 (6) 1478-1485; DOI: https://doi.org/10.1124/mol.59.6.1478
  • You have access
    Transcriptional Modulation of Mouse μ-Opioid Receptor Distal Promoter Activity by Sox18
    Hee-Jeong Im, Dmitri Smirnov, Tomoaki Yuhi, Shalini Raghavan, Jane E. Olsson, George E. Muscat, Peter Koopman and Horace H. Loh
    Molecular Pharmacology June 2001, 59 (6) 1486-1496; DOI: https://doi.org/10.1124/mol.59.6.1486
  • You have access
    Effect of Poly(ADP-Ribose) Polymerase Inhibitors on the Ischemia-Reperfusion-Induced Oxidative Cell Damage and Mitochondrial Metabolism in Langendorff Heart Perfusion System
    Robert Halmosi, Zoltan Berente, Erzsebet Osz, Kalman Toth, Peter Literati-Nagy and Balazs Sumegi
    Molecular Pharmacology June 2001, 59 (6) 1497-1505; DOI: https://doi.org/10.1124/mol.59.6.1497
  • You have access
    Prostaglandin F2α Receptor-Dependent Regulation of Prostaglandin Transport
    Roberta Vezza, Joshua Rokach and Garret A. FitzGerald
    Molecular Pharmacology June 2001, 59 (6) 1506-1513; DOI: https://doi.org/10.1124/mol.59.6.1506
  • You have access
    Interactions between 3-(Trifluoromethyl)-3-(m-[125I]iodophenyl)diazirine and Tetracaine, Phencyclidine, or Histrionicotoxin in theTorpedo Species Nicotinic Acetylcholine Receptor Ion Channel
    Martin J. Gallagher, David C. Chiara and Jonathan B. Cohen
    Molecular Pharmacology June 2001, 59 (6) 1514-1522; DOI: https://doi.org/10.1124/mol.59.6.1514
  • You have access
    ADP-Ribosylation Factor-Dependent Phospholipase D Activation by VPAC Receptors and a PAC1 Receptor Splice Variant
    Derek A. McCulloch, Eve M. Lutz, Melanie S. Johnson, Derek N. Robertson, Chris J. MacKenzie, Pamela J. Holland and Rory Mitchell
    Molecular Pharmacology June 2001, 59 (6) 1523-1532; DOI: https://doi.org/10.1124/mol.59.6.1523
  • You have access
    Adenosine A1 Receptor-Mediated Inhibition of Protein Kinase A-Induced Calcitonin Gene-Related Peptide Release from Rat Trigeminal Neurons
    Alan M. Carruthers, Lynda A. Sellers, David W. Jenkins, Emma M. Jarvie, Wasyl Feniuk and Patrick P. A. Humphrey
    Molecular Pharmacology June 2001, 59 (6) 1533-1541; DOI: https://doi.org/10.1124/mol.59.6.1533
  • You have access
    Role of the Human Concentrative Nucleoside Transporter (hCNT1) In the Cytotoxic Action of 5[Prime]-Deoxy-5-fluorouridine, an Active Intermediate Metabolite of Capecitabine, a Novel Oral Anticancer Drug
    João F. Mata, José M. Garcı́a-Manteiga, M. Pilar Lostao, Sonia Fernández-Veledo, Elena Guillén-Gómez, Ignacio M. Larrayoz, Jorge Lloberas, F. Javier Casado and Marçal Pastor-Anglada
    Molecular Pharmacology June 2001, 59 (6) 1542-1548; DOI: https://doi.org/10.1124/mol.59.6.1542
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 59 (6)
Molecular Pharmacology
Vol. 59, Issue 6
1 Jun 2001
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts

Jump to

  • Perspective
  • Accelerated Communications
  • Articles
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics